3rd Quarter - Report
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to reimbursement under Medicare Part B and Part D; Most Favored Nation (MFN).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CASEY DAVISON | — |
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Health Issues HCR
Issues related to drug pricing, generally; 340B Drug Pricing Program; most favored nation drug pricing; Pandemic All-Hazards Preparedness Act (PAHPA) reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| CASEY DAVISON | — |
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Pharmacy PHA
Pharmacy Benefit Manager reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CASEY DAVISON | — |
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.